LLASHNEWSMedical aesthetics media & sourcingRequest Quote
RegulatoryAesthetic DevicesInjectables

【Malaysia Put】Malaysia Health Ministry: Only Act 586-Registered Premises May Provide Healthcare, Including Aesthetic Services

Source image preserved for article context.
Editor's note

This enforcement update, sourced from the Malaysian Health Ministry, signals heightened regulatory scrutiny for aesthetic clinics. Overseas suppliers of devices and injectables must ensure their local partners only supply Act 586-registered premises to avoid supply-chain disruptions and legal liability.

The Malaysian Health Ministry has reaffirmed that healthcare services, including aesthetic medical treatments, must only be provided at premises registered or licensed under the Private Healthcare Facilities and Services Act 1998 (Act 586). Unregistered or unlicensed operations face fines up to RM500,000, imprisonment up to six years, or both. This enforcement signal is critical for overseas aesthetic device and injectable distributors supplying the Malaysian market, as non-compliant clinics risk shutdown and legal action.

Regulatory enforcement intensifies

The ministry reported over 1,020 complaints from 2021 to date regarding healthcare services at unregistered or unlicensed premises, with numbers rising annually. Since 2021, 320 raids have been conducted, leading to 126 investigation papers, 194 warnings or advisories, and 70 court cases. Enforcement includes intelligence-based operations and coordination with state health departments.

Aesthetic services under scrutiny

The ministry specifically noted an increase in complaints about aesthetic medical services being performed at unregistered or unlicensed locations. This indicates heightened regulatory focus on the aesthetics sector, where non-compliant clinics may use unapproved devices or injectables. Distributors should verify that their downstream clinic partners hold valid Act 586 registration.

What buyers should watch

Overseas suppliers of aesthetic devices, injectables, and consumables to Malaysia should ensure their local importers and distributor partners only supply to Act 586-registered premises. Non-compliance by end-users could disrupt supply chains and create legal liability. The ministry encourages reporting via [email protected], signaling active monitoring.

Sourcing context

This announcement reinforces Malaysia's regulatory framework for private healthcare facilities. For B2B buyers, due diligence on clinic licenses is now more critical than ever. The RM500,000 fine and potential imprisonment underscore the seriousness of non-compliance, affecting both local operators and international partners.

Source: Read the original report | Published: June 03, 2026